Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476526 · ClinicalTrials.gov registry record · Phase 4
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
A Phase 4 study, sponsored by VA Greater Los Angeles Healthcare System.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT02476526: Completed Phase 4 study, sponsored by VA Greater Los Angeles Healthcare System.
NCT02476526 is a Phase 4 study that has completed, run by VA Greater Los Angeles Healthcare System. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02476526, a Phase 4 study, has completed, sponsored by VA Greater Los Angeles Healthcare System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to show that the use of low volume iso-osmolar non-ionic radio contrast medium (30 cc) in a thoracic CT Scanning procedure in a selected group of patients with chronic kidney disease (CKD) will avoid contrast induced nephropathy (CIN) in comparison to a similar group of patients with CKD who receive no contrast medium..
Primary Outcome
The peak serum creatinine increase over baseline within 72 hours after intervention is the outcome variable. This variable is used for comparison between two groups, as well as for safety monitoring in the intervention group (25% increase is the upper threshold)
Interventions
- DRUG Low Volume iso-osmolar non-ionic radio contrast medium
- DRUG Acetylcysteine Inhalation
- DRUG Sodium Bicarbonate Solution
- PROCEDURE 64-MDCT Scanning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-09 |
| Est. Completion | 2017-11-20 |
| Phase | Phase 4 |
What the finished NCT02476526 record still lists
NCT02476526 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 4 interventions - of which Low Volume iso-osmolar non-ionic radio contrast medium is the first listed.
NCT02476526 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02476526 about?
NCT02476526 is a clinical study titled "Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease". The purpose of this study is to show that the use of low volume iso-osmolar non-ionic radio contrast medium (30 cc) in a thoracic CT Scanning procedure in a selected group of patients with chronic kidney disease (CKD) will avoid contrast induced nephropathy (CIN) in comparison to a similar group of ...
What is the current status of trial NCT02476526?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2008-09. Estimated completion is 2017-11-20.
What interventions are being tested in trial NCT02476526?
The interventions under investigation include: Low Volume iso-osmolar non-ionic radio contrast medium (DRUG), Acetylcysteine Inhalation (DRUG), Sodium Bicarbonate Solution (DRUG), 64-MDCT Scanning (PROCEDURE).
Who is sponsoring clinical trial NCT02476526?
This trial is sponsored by VA Greater Los Angeles Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02476526's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia